An Act to ensure access to prescription medications
This bill (SD 85) establishes rules for pharmacy benefits managers and covered entities regarding reimbursement rates for prescription drugs. It requires that drugs placed on "maximum allowable cost lists" (reimbursement limits) must meet specific FDA rating criteria and have therapeutically equivalent alternatives available. Pharmacies must receive transparent cost information, and reimbursement rates must cover actual pharmacy acquisition costs (using National Average Drug Acquisition Cost as a benchmark). The bill also creates a 7-business-day appeals process for pharmacies to challenge rates, with retroactive payment adjustments if appeals are approved, and prohibits retroactive discounts on claims. These requirements apply to all pharmacy benefits managers and covered entities operating in Massachusetts.
Bill status
passed
3 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Dec 2025
House Passage
Feb 2025
Governor
Introduced Feb 27, 2025
Last action Jan 29, 2026
Floor votes
How they voted
This bill passed the House. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
6
Key actions
2
Committee
2
Dec 4, 2025
Upper · Passed
Bill reported favorably by committee and referred to the committee on Health Care Financing
upper
Feb 27, 2025
Lower · Passed
House concurred
lower
Feb 27, 2025
Committee
Referred to the committee on Financial Services
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 827
Scope: MA
Hi! I can help you understand S 827. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline